The national effort to return the Medicaid enrollment process to its pre-pandemic rules starting in April 2023 may have disrupted the care of people receiving treatment for opioid addiction, a new study finds. The data have implications for current Medicaid budget discussions.
Two HSS studies received awards from the American Society of Regional Anesthesia and Pain Medicine. One looked at the prevalence of CBD use in patients scheduled for sports medicine surgery. The other compared the need for opioid medication after robotic, computer-assisted or manual hip replacement.
America’s Poison Centers is monitoring the National Poison Data System (NPDS) for cases of Vitamin A toxicity. Between January 1 and March 31, 2025, there have been 86 pediatric Vitamin A exposures reported to U.S. Poison Centers representing a 38.7% increase compared to the same period in 2024.
This news release is embargoed until 28-Apr-2025 5:00 PM EDT
Released to reporters: 22-Apr-2025 7:45 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 28-Apr-2025 5:00 PM EDT
The Ҵý PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Background: Motivational interviewing (MI) is frequently used to facilitate behavior change. The use of change talk during motivational interviews can predict subsequent behavior change. However, no studies have compared the informat...
Ines Ibañez-Tallon is revealing how an understudied region of the brain plays an outsized role in opioid and nicotine dependence.
Not for public release
This news release is embargoed until 21-Apr-2025 5:00 PM EDT
Released to reporters: 15-Apr-2025 7:55 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 21-Apr-2025 5:00 PM EDT
The Ҵý PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
The April issue of the Journal of the American College of Surgeons (JACS), which includes research presented at the Southern Surgical Association 136th Annual Meeting, features new findings.
Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to neutralize a broad diversity of SARS-CoV-2 variants.
Patients hospitalized with opioid use disorders who receive addiction consultation services are significantly more likely to start medication treatment and access follow-up care when compared with patients who receive standard or usual care, a study co-led by Cedars-Sinai investigators found.
Not for public release
This news release is embargoed until 4-Apr-2025 10:15 AM EDT
Released to reporters: 4-Apr-2025 10:15 AM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 4-Apr-2025 10:15 AM EDT
The Ҵý PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Not for public release
This news release is embargoed until 4-Apr-2025 10:00 AM EDT
Released to reporters: 31-Mar-2025 7:35 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 4-Apr-2025 10:00 AM EDT
The Ҵý PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development. The new Center will integrate AI with traditional drug discovery methods to identify and design new small-molecule therapeutics with unprecedented speed and precision.
Unlike conventional drug discovery, which can take years and cost billions, AI-driven approaches enable researchers to rapidly navigate a vast chemical landscape, including natural products, to pinpoint promising drug candidates. By leveraging Mount Sinai’s world-leading expertise in machine learning, chemical biology, and biomedical data science, the Center aims to bring innovative treatments to patients faster—particularly for diseases with urgent unmet needs, including cancer, metabolic disorders, and neurodegenerative diseases.
recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid prescriptions by implementing Enhanced Recovery After Surgery (ERAS) pathways.
The study, led by researchers from the Rothman Opioid Foundation, Goldfinch Health, and Drexel University College of Medicine, examined the impact of ERAS protocols on opioid prescribing to patients undergoing arthroplasty (joint replacement surgery) and arthroscopy (a minimally invasive procedure to diagnose and treat joint issues). Arthroplasty involves replacing damaged joints with prosthetic implants to relieve pain and restore function, whereas arthroscopy utilizes a small camera to examine and repair joint damage through small incisions.
Young adults in pain start using cannabis earlier and are more likely to mix it with alcohol, according to new research from Binghamton University, State University of New York.
Researchers at UC San Diego have confirmed the presence of xylazine in the illicit drug supply at the U.S.-Mexico border. While xylazine remains less common in the Western U.S., border cities serve as key trafficking hubs and may have higher rates of emerging substances.
Not for public release
This news release is embargoed until 17-Mar-2025 5:00 PM EDT
Released to reporters: 11-Mar-2025 8:50 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 17-Mar-2025 5:00 PM EDT
The Ҵý PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.